Generics makers appeal pay-for-delay ban to Ninth Circuit

A group of generics manufacturers yesterday, December 2 asked the US Court of Appeals for the Ninth Circuit to reverse California’s ban on pay-for-delay deals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

More on this story

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

More on this story

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California outlaws pay-for-delay deals

9 October 2019 California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.